BMS-986393
bms
['fil,veral,12', 'daratumumab', ' lena', 'mmsm', 'tocilizumab', 'toci', 'mm-001', 'lenalidomide', 'cc-98633', 'cc,98633,mm,001', 'pomalidomide', 'bortezomib', 'multiple myeloma', 'borte', 'anakinra', 'carfilzomib', 'emergent ', 'adaptive ']
#ash22 #mmsm oral session- cc-98633-mm-001 40% emd, stage iii r-iss 8% toxicity: any g3/4 in 83% ( high incidence- hematological), crs and icans low grade orr: 95% overall , responses short follow up, swimmer plot 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities